Literature DB >> 34724122

The verification of the reliability of a triglyceride-glucose index and its availability as an advanced tool.

Sarang Jeong1, Jong Ho Lee2.   

Abstract

BACKGROUND: The triglyceride-glucose (TyG) index has been considered as insulin resistance (IR) assessment index. The current study aimed to verify the reliability of the TyG index as an IR assessment marker; the study of plasma fatty acids and body fat composition to determine potential metabolic syndrome (MetS) participants with a body mass index (BMI) of between 25.0 and 29.9 kg/m2.
METHODS: The study included 378 overweight participants with a body mass index of between 25.0 and 29.9 kg/m2. They were divided into tertiles according to the homeostasis model assessment of IR (HOMA-IR) or the TyG index. The role of the IR assessment index and the relationship with IR-related diseases and the risk factors using gas chromatograph-mass spectrometry, computed tomography, and dual energy X-ray absorptiometry, was investigated.
RESULTS: It was only in the TyG index tertile that the higher TyG index participants showed considerably higher LDL-cholesterol levels. More markedly, a close relationship was observed between the TyG index and the omega-6 polyunsaturated fatty acids compared with the HOMA-IR. Unlike HOMA-IR, with regard to the risks of developing chronic diseases, the MetS, the third tertile of the TyG index, showed an approximately 33.7 times greater odds ratio (OR) of the MetS occurring, compared with the first tertile of the TyG index.
CONCLUSIONS: The TyG index may be considered as an IR assessment index. In addition, the TyG index is an advanced tool that reflects the relevance of pro-inflammation levels and the presence of IR-related chronic diseases.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Computed tomography, CT; Dual energy X-ray absorptiometry, DEXA; Gas chromatograph-mass spectrometry, GC–MS; Homeostasis model assessment of insulin resistance, HOMA-IR; Insulin resistance, IR; Triglyceride–glucose index, TyG index

Mesh:

Substances:

Year:  2021        PMID: 34724122     DOI: 10.1007/s11306-021-01837-9

Source DB:  PubMed          Journal:  Metabolomics        ISSN: 1573-3882            Impact factor:   4.290


  1 in total

1.  Prevalence, Risk Factors, and Genetic Traits in Metabolically Healthy and Unhealthy Obese Individuals.

Authors:  A Berezina; O Belyaeva; O Berkovich; E Baranova; T Karonova; E Bazhenova; D Brovin; E Grineva; E Shlyakhto
Journal:  Biomed Res Int       Date:  2015-10-04       Impact factor: 3.411

  1 in total
  4 in total

1.  TyG index is positively associated with risk of CHD and coronary atherosclerosis severity among NAFLD patients.

Authors:  Jianqi Zhao; Hongxuan Fan; Ting Wang; Bing Yu; Shaobin Mao; Xun Wang; Wenjing Zhang; Leigang Wang; Yao Zhang; Zhaoyu Ren; Bin Liang
Journal:  Cardiovasc Diabetol       Date:  2022-07-01       Impact factor: 8.949

2.  Evaluation of the long-term prognostic ability of triglyceride-glucose index for elderly acute coronary syndrome patients: a cohort study.

Authors:  Yang Jiao; Yongkang Su; Jian Shen; Xiaoling Hou; Ying Li; Jihang Wang; Bing Liu; Dongfeng Qiu; Zhijun Sun; Yundai Chen; Qing Xi; Mingzhi Shen; Zhenhong Fu
Journal:  Cardiovasc Diabetol       Date:  2022-01-06       Impact factor: 9.951

3.  Triglyceride-glucose index and common carotid artery intima-media thickness in patients with ischemic stroke.

Authors:  Mengyuan Miao; Guo Zhou; Anran Bao; Yaming Sun; Huaping Du; Liyan Song; Yongjun Cao; Shoujiang You; Chongke Zhong
Journal:  Cardiovasc Diabetol       Date:  2022-03-18       Impact factor: 9.951

4.  The predictive value of the triglyceride-glucose index for cardiovascular events in patients with coronary chronic total occlusion.

Authors:  Yingkai Li; Songyuan He; Zheng Wu; Wenzheng Li; Wen Jian; Zichao Cheng; Cong Wang; Yuchen Shi; Jinghua Liu
Journal:  Cardiovasc Diabetol       Date:  2022-08-08       Impact factor: 8.949

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.